Igene Biotechnology Company Top Management

Evaluation of Igene Biotechnology's management performance can provide insight into the firm performance.
Joseph Downs  Insider
Chief Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Igene Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Igene Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of (0.0821) % which means that it has lost $0.0821 on every $100 spent on assets. This is way below average. Igene Biotechnology's management efficiency ratios could be used to measure how well Igene Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

Igene Biotechnology Workforce Comparison

Igene Biotechnology is currently regarded as number one stock in number of employees category among its peers. The total workforce of Materials industry is currently estimated at about 129. Igene Biotechnology retains roughly 18.0 in number of employees claiming about 14% of all equities under Materials industry.

Igene Biotechnology Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Igene Biotechnology Price Series Division is a division of Igene Biotechnology price series and its benchmark/peer.

Igene Biotechnology Stakeholder

Joseph DownsChief OfficerProfile

About Igene Biotechnology Management Performance

The success or failure of an entity such as Igene Biotechnology often depends on how effective the management is. Igene Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Igene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Igene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland. IGENE BIOTECHNOLOGY operates under Agricultural Inputs classification in the United States and is traded on PNK Exchange. It employs 18 people.
Please note, the presentation of Igene Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Igene Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Igene Biotechnology's management manipulating its earnings.

Igene Biotechnology Workforce Analysis

Traditionally, organizations such as Igene Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Igene Biotechnology within its industry.

Igene Biotechnology Manpower Efficiency

Return on Igene Biotechnology Manpower

Revenue Per Employee219.9K
Net Loss Per Employee7.8K
Working Capital Per Employee17.3K

Complementary Tools for Igene Pink Sheet analysis

When running Igene Biotechnology's price analysis, check to measure Igene Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Igene Biotechnology is operating at the current time. Most of Igene Biotechnology's value examination focuses on studying past and present price action to predict the probability of Igene Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Igene Biotechnology's price. Additionally, you may evaluate how the addition of Igene Biotechnology to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal